Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New pneumococcal vaccines for children.

Literature DB >> 11259222

New pneumococcal vaccines for children.

S Choo¹, A Finn.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2001 PMID： 11259222 PMCID： PMC1718703 DOI： 10.1136/adc.84.4.289

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

× No keyword cloud information.

55 in total

1. Pneumonia in childhood: etiology and response to antimicrobial therapy.

Authors: O Ruuskanen; H Nohynek; T Ziegler; R Capeding; H Rikalainen; P Huovinen; M Leinonen
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-03 Impact factor: 3.267

2. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland.

Authors: C Jokinen; L Heiskanen; H Juvonen; S Kallinen; K Karkola; M Korppi; S Kurki; P R Rönnberg; A Seppä; S Soimakallio
Journal: Am J Epidemiol Date: 1993-05-01 Impact factor: 4.897

3. Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection.

Authors: J C King; P E Vink; J J Farley; M Smilie; M Parks; R Lichenstein
Journal: Pediatrics Date: 1997-04 Impact factor: 7.124

4. Invasive pneumococcal disease in England and Wales: vaccination implications.

Authors: K Sleeman; K Knox; R George; E Miller; P Waight; D Griffiths; A Efstratiou; K Broughton; R T Mayon-White; E R Moxon; D W Crook
Journal: J Infect Dis Date: 2000-12-21 Impact factor: 5.226

5. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine.

Authors: J C Butler; R F Breiman; H B Lipman; J Hofmann; R R Facklam
Journal: J Infect Dis Date: 1995-04 Impact factor: 5.226

6. Outcomes of bacterial meningitis in children: a meta-analysis.

Authors: L J Baraff; S I Lee; D L Schriger
Journal: Pediatr Infect Dis J Date: 1993-05 Impact factor: 2.129

7. Epidemiology of invasive pneumococcal infections in children in Finland.

Authors: J Eskola; A K Takala; E Kela; E Pekkanen; R Kalliokoski; M Leinonen
Journal: JAMA Date: 1992-12-16 Impact factor: 56.272

8. Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media.

Authors: A Virolainen; P Salo; J Jero; P Karma; J Eskola; M Leinonen
Journal: J Clin Microbiol Date: 1994-11 Impact factor: 5.948

Review 8. Acute upper airway infections.

Authors: J V West
Journal: Br Med Bull Date: 2002 Impact factor: 4.291

8 in total

New pneumococcal vaccines for children.

1. Pneumonia in childhood: etiology and response to antimicrobial therapy.

2. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland.

3. Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection.

4. Invasive pneumococcal disease in England and Wales: vaccination implications.

5. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine.

6. Outcomes of bacterial meningitis in children: a meta-analysis.

7. Epidemiology of invasive pneumococcal infections in children in Finland.

8. Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media.

9. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b.

10. Aetiology of community-acquired pneumonia in children treated in hospital.

Review 1. Lumbar puncture following febrile convulsion.

Review 2. Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Review 3. Advances in pneumococcal vaccines: advantages for infants and children.

4. Modelling the unidentified mortality burden from thirteen infectious pathogenic microorganisms in infants.

5. Investigation of daytime wetting: when is spinal cord imaging indicated?

Review 6. Should the new pneumococcal vaccine be used in high-risk children?

7. Laboratory-based surveillance of patients with bacterial meningitis in Egypt (1998-2004).

Review 8. Acute upper airway infections.